Medtronic PLC | Cash Flow

Fiscal year is May-April. All values USD Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
3,065
2,675
3,538
4,024
3,095
4,650
Depreciation, Depletion & Amortization
850
1,306
2,820
2,917
2,644
2,659
Other Funds
13
116
60
16
50
1,082
Funds from Operations
3,986
4,105
6,621
6,741
4,857
8,087
Changes in Working Capital
973
797
1,403
139
173
1,080
Net Operating Cash Flow
4,959
4,902
5,218
6,880
4,684
7,007
Capital Expenditures
396
571
1,046
1,254
1,068
Sale of Fixed Assets & Businesses
-
-
-
-
6,058
Purchase/Sale of Investments
2,784
1,692
4,518
985
1,027
Net Investing Cash Flow
3,594
17,058
2,245
1,571
5,858
Cash Dividends Paid - Total
1,116
1,337
2,139
2,376
2,494
Issuance/Reduction of Debt, Net
1,431
18,673
5,125
2,193
7,642
Net Financing Cash Flow
918
15,949
9,543
3,283
11,954
Net Change in Cash
484
3,440
1,967
2,091
1,298
Free Cash Flow
4,563
4,331
4,172
5,626
3,616
Deferred Taxes & Investment Tax Credit
207
926
460
459
919
304
Net Assets from Acquisitions
385
14,884
1,213
1,324
137
Other Sources
-
89
-
22
-
Change in Capital Stock
1,246
1,271
2,339
3,116
1,768
Exchange Rate Effect
37
353
113
65
114
Other Uses
29
-
14
-
22

About Medtronic

View Profile
Address
20 On Hatch
Dublin Dublin 2
Ireland
Employees -
Website http://www.medtronic.com
Updated 07/08/2019
Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group.